Primary pharmaceutical packaging is the material that is in direct contact with the drug product, serving as the first and most critical layer of protection. For parenteral drugs, primary packaging includes vials, ampoules, syringes, cartridges, and other containers that hold the sterile drug formulation. The selection of primary packaging materials is critical for ensuring drug stability, safety, and efficacy. The primary packaging must be compatible with the drug product, provide an effective barrier against moisture, oxygen, and light, and maintain sterility throughout the product's shelf life. Glass has been the traditional material of choice for primary packaging due to its inertness and barrier properties [citation:MRFR]. However, plastic materials, such as COC, COP, and PP, are increasingly being used for their lightweight and breakage-resistant properties [citation:MRFR]. The development of new materials and coatings is continuously improving the performance of primary packaging. For instance, COP vials launched by SCHOTT are designed to enhance the stability and safety of sensitive biologic drugs [citation:MRFR]. Elastomeric components, such as rubber stoppers and plungers, are also critical parts of primary packaging systems, providing a seal and allowing for needle penetration.

Regulatory bodies, such as the FDA and EMA, have strict requirements for primary packaging materials, including biocompatibility, extractable and leachable testing, and stability studies. The demand for primary pharmaceutical packaging is driven by the increasing number of new drug approvals, the expansion of the biologics sector, and the growing focus on patient safety. By 2035, primary pharmaceutical packaging will continue to be a focus of innovation, with manufacturers developing materials and systems that enhance drug stability, safety, and delivery.

Get More Insights: Parenteral Packaging Market Report